EMEA-001990-PIP01-16-M05
Key facts
| Active substance |
Fenfluramine hydrochloride
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0390/2022
|
| PIP number |
EMEA-001990-PIP01-16-M05
|
| Pharmaceutical form(s) |
Oral solution
|
| Condition(s) / indication(s) |
Treatment of Dravet syndrome
|
| Route(s) of administration |
|
| Contact for public enquiries |
Zogenix International Ltd
Email: medinfo.eu@zogenix.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|